BrookeWorsterMD

Hospice & Palliative Medicine, Pain Medicine

Director, Division of Supportive Oncology Associate Professor, Medical Oncology Medical Director, MS Cannabis Medicine, Science and Business

Dr. Worster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
925 Chestnut St
# 420A
Philadelphia, PA 19107
Phone+1 215-955-1888

Fax+1 215-503-3152

Brooke Worster, MD, is an internal medicine specialist based in Philadelphia, PA, with a focus on Hospice & Palliative Medicine and Pain Medicine. She completed her education and residency at the Lewis Katz School of Medicine at Temple University and Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's Hospital respectively. Currently, Dr. Worster serves as the Division Director of Supportive Oncology at Jefferson Health and the Medical Director of Palliative Care Service at Thomas Jefferson University Hospitals. She has significant contributions to medical literature, with numerous publications in esteemed journals, and she has taken part in various clinical trials mainly focused on the use of cannabis in cancer treatment and telehealth care.

Massachusetts General Hospital/Dana-Farber Cancer Institute/Children's Hospital BostonFellowship, Hospice and Palliative Medicine, 2012
Temple University HospitalResidency, Internal Medicine, 2007 - 2010
Lewis Katz School of Medicine at Temple UniversityClass of 2007
Temple University HospitalChief Residency, Internal Medicine

Cannabis Use Patterns Among Cancer Patients Start of enrollment: 2021 Feb 25
Completed
Roles: Contact
Telehealth-enabled Integrated Palliative Care for People With Dementia Start of enrollment: 2022 Jun 29
Active, not recruiting
Not Applicable
Roles: Principal Investigator, Contact
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer Start of enrollment: 2024 May 30
Not yet recruiting
Roles: Contact

PubMed

1 citations
Impact of Head and Neck Cancer Diagnosis and Treatment on Patient-Partner Intimacy.
Michele Fiorella, Angela Alnemri, Sarah Sussman, Anusha Koka, Jennifer Johnson
Otolaryngology--Head and Neck Surgery. 2023-09-01
5 citations
Clinician Attitudes, Training, and Beliefs About Cannabis: An Interprofessional Assessment.
Brooke Worster, Rebecca L Ashare, Emily Hajjar, Greg Garber, Kelsey Smith
Cannabis and Cannabinoid Research. 2023-06-01
4 citations
Increasing equitable access to telehealth oncology care in the COVID-19 National Emergency: Creation of a telehealth task force.
Brooke Worster, Lauren Waldman, Gregory Garber, Tingting Zhan, AnaMaria Lopez
Cancer Medicine. 2023-02-01

Lectures

Proactive, multidisciplinary approach to supportive medicine: Improving health outcomes and care utilization.
2019 ASCO Annual Meeting - 6/1/2019

Cannabis in Cancer: What Oncologists and Patients Should KnowOctober 22nd, 2024
Independence Blue Cross and Jefferson Health Study Published in the Journal Cancer Finds Outpatient Supportive Oncology Programs Improve Care and Reduce CostsAugust 6th, 2024
Independence Blue Cross Awards 2022 Clinical Care Innovation Grants to Jefferson Health, Temple Health, Penn Medicine, and Trinity Health Mid-AtlanticJuly 8th, 2022
Join now to see all